Article
Targeting stem cells in myelodysplastic syndromes and acute myeloid leukemia
13 Jul 2022
Abstract excerpt
The genetic architecture of cancer has been delineated through advances in high-throughput next-generation sequencing, where the sequential acquisition of recurrent driver mutations initially targeted towards normal cells ultimately leads to malignant transformation. Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) are hematologic malignancies frequently initiated by mutations in the normal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
